Status:
COMPLETED
Preventing Adverse Drug Events With PatientSite
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Blue Cross Blue Shield
Conditions:
Adverse Drug Event
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a study to better understand the nature and extent of adverse drug events (ADEs), defined as injuries due to prescription medications, in primary care. We will study whether PatientSite (an in...
Detailed Description
* A drug safety module called MedCheck was developed for PatientSite. This allows physicians to query patients automatically 10 days after they receive a new prescription asking them questions about t...
Eligibility Criteria
Inclusion
- Adult patients \>18
- Patients that receive a new prescription
- Proficient in spoken and written english
Exclusion
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2004
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00140504
Start Date
April 1 2003
End Date
December 1 2004
Last Update
February 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215